These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16306086)

  • 1. Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action.
    Harrington WR; Kim SH; Funk CC; Madak-Erdogan Z; Schiff R; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Endocrinol; 2006 Mar; 20(3):491-502. PubMed ID: 16306086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors.
    Madak-Erdogan Z; Kieser KJ; Kim SH; Komm B; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Endocrinol; 2008 Sep; 22(9):2116-27. PubMed ID: 18617595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus.
    Yang LC; Zhang QG; Zhou CF; Yang F; Zhang YD; Wang RM; Brann DW
    PLoS One; 2010 May; 5(5):e9851. PubMed ID: 20479872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity.
    Santen RJ; Song RX; Zhang Z; Kumar R; Jeng MH; Masamura A; Lawrence J; Berstein L; Yue W
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S61-73. PubMed ID: 16113100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive mechanisms induced by long-term estrogen deprivation in breast cancer cells.
    Song RX; Santen RJ; Kumar R; Adam L; Jeng MH; Masamura S; Yue W
    Mol Cell Endocrinol; 2002 Jul; 193(1-2):29-42. PubMed ID: 12160999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells.
    Rai D; Frolova A; Frasor J; Carpenter AE; Katzenellenbogen BS
    Mol Endocrinol; 2005 Jun; 19(6):1606-17. PubMed ID: 15831524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of adapter protein Shc in estrogen non-genomic action.
    Zhang Z; Kumar R; Santen RJ; Song RX
    Steroids; 2004 Aug; 69(8-9):523-9. PubMed ID: 15288764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of estrogen receptor ligands leading to activation of non-genomic signaling pathways while exhibiting only weak transcriptional activity.
    Wessler S; Otto C; Wilck N; Stangl V; Fritzemeier KH
    J Steroid Biochem Mol Biol; 2006 Jan; 98(1):25-35. PubMed ID: 16203130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase.
    Greger JG; Fursov N; Cooch N; McLarney S; Freedman LP; Edwards DP; Cheskis BJ
    Mol Cell Biol; 2007 Mar; 27(5):1904-13. PubMed ID: 17194752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
    Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
    Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase.
    Gaben AM; Saucier C; Bedin M; Redeuilh G; Mester J
    Mol Endocrinol; 2004 Nov; 18(11):2700-13. PubMed ID: 15297603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct nongenomic signal transduction pathways controlled by 17beta-estradiol regulate DNA synthesis and cyclin D(1) gene transcription in HepG2 cells.
    Marino M; Acconcia F; Bresciani F; Weisz A; Trentalance A
    Mol Biol Cell; 2002 Oct; 13(10):3720-9. PubMed ID: 12388769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive hypersensitivity to estrogen: mechanism for sequential responses to hormonal therapy in breast cancer.
    Santen RJ; Song RX; Zhang Z; Yue W; Kumar R
    Clin Cancer Res; 2004 Jan; 10(1 Pt 2):337S-45S. PubMed ID: 14734489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways.
    Fox EM; Andrade J; Shupnik MA
    Steroids; 2009 Jul; 74(7):622-7. PubMed ID: 18996136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
    Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
    Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions.
    Björnström L; Sjöberg M
    Mol Endocrinol; 2002 Oct; 16(10):2202-14. PubMed ID: 12351686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.
    Caristi S; Galera JL; Matarese F; Imai M; Caporali S; Cancemi M; Altucci L; Cicatiello L; Teti D; Bresciani F; Weisz A
    Cancer Res; 2001 Sep; 61(17):6360-6. PubMed ID: 11522626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells.
    Chang M; Peng KW; Kastrati I; Overk CR; Qin ZH; Yao P; Bolton JL; Thatcher GR
    Endocrinology; 2007 Oct; 148(10):4793-802. PubMed ID: 17584965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling from the membrane via membrane estrogen receptor-alpha: estrogens, xenoestrogens, and phytoestrogens.
    Watson CS; Bulayeva NN; Wozniak AL; Finnerty CC
    Steroids; 2005; 70(5-7):364-71. PubMed ID: 15862819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo characterization of estrogen receptor modulators with reduced genomic versus nongenomic activity in vitro.
    Otto C; Fuchs I; Altmann H; Klewer M; Schwarz G; Bohlmann R; Nguyen D; Zorn L; Vonk R; Prelle K; Osterman T; Malmström C; Fritzemeier KH
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):95-100. PubMed ID: 18606537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.